Welcome to the first edition. The deal: a 4-minute skim of what actually happened, then a longer read that connects the moves and takes a position. We follow a roster of high-signal minds and link to their primary work — the paper, the post, the talk — not the hype around it. Quality over noise. Let's go.

"The 10 AI agents you must use this week." The genre is back in full force — and it skips the only question your org actually has: is your data even agent-ready? Andrew Ng's answer is no, for most enterprises, and the tool list doesn't change that. A flashy agent on top of siloed, human-permissioned data is a demo, not a deployment. Skim the lists for awareness; don't build a strategy on them.

This week had no single blockbuster launch. It had something more useful for anyone making decisions: a set of moves that, lined up, tell you what the smartest people in the field actually believe — and where they disagree. Three threads.

When a Nobel laureate (Jumper), a transformer co-author (Shazeer), and the field's most influential teacher (Karpathy) all change labs inside a few weeks, that's not gossip — it's a leading indicator. Two patterns stand out. First, science-for-AI is a front line: Jumper's move says the labs want people who can turn AI loose on hard scientific problems, not just chatbots. Second, the talent is clustering around pre-training and the use of AI to do AI research — exactly where Karpathy landed, and exactly the capability Anthropic simultaneously published caution about (Thread 3).

The lesson: you don't need insider access to read the frontier's priorities. Watch where decorated people go and what teams they join; the org chart leaks the roadmap that the keynote won't.

It's easy to treat "is scaling enough?" as a Twitter argument. It stopped being one this week. LeCun and Fei-Fei Li — two of the most credentialed skeptics of "language models are the path" — each put roughly a billion dollars behind world models, and they're not even taking the same route: LeCun's AMI Labs is betting on JEPA (learning abstract representations by predicting missing parts of a scene), while Li's World Labs is betting on spatial intelligence (reasoning about 3D geometry and physics). Li's renderer/simulator/planner taxonomy is the first crisp map of the territory.

The lesson: the people best positioned to know are hedging against "scale is all you need." For an operator, the takeaway isn't to pick a side — it's that betting your roadmap on a single paradigm is now a visible risk. The next leg of capability may not come from the model you're standardizing on.

The same week the talent clustered around recursive, self-improving research loops, Anthropic published a paper arguing the field should be ready to slow exactly that down, and the major-lab CEOs jointly asked Congress to mandate synthetic-DNA screening. Read together with the EU's Cloud and AI Development Act and fresh U.S. export controls, governance is shifting from afterthought to gating function — and notably, some of the loudest calls are coming from inside the labs, not just from critics.

The lesson: "governance" is no longer a compliance footnote you handle after you ship. For regulated industries especially, the binding date can arrive before the capability does — see the June 30 health-AI enforcement in Quick Hits.

If you run strategy rather than a lab, the model leaderboard is the least useful thing you can track. The signal this week was elsewhere: talent flows tell you where the next gains are expected, a genuine paradigm debate tells you not to over-commit to one architecture, and governance tells you what you'll actually be allowed to deploy. The most underrated story is the dullest one — Andrew Ng's point that the work is data plumbing and human judgment, not tool adoption. That's where the returns are, and it's the opposite of the "10 agents you need" feed.

The honest counter-case: talent moves can be about money and ego as much as conviction, world-model startups have shipped far less than LLM labs, and "we should slow down" is cheap to say and hard to do while you're hiring the people speeding it up. All true. Watch the behavior, not the press release — which is the whole point.

Whether any frontier lab pairs a capability release with a concrete recursive-self-improvement safeguard — not a blog post. That's the tell for whether Thread 3 is conviction or positioning.

Got a mind we should be reading, or a correction? Reply and tell us.

Debut-edition note: this issue was assembled from public reporting for the week of June 15–21, 2026. Items marked "reported" are as-reported and not independently confirmed; we link primary sources where they exist and hedge where they don't — that's the house style.

AI Above the Cut is a weekly brief for executives — VP-and-up leaders in strategy, healthcare, and AI transformation who want signal over noise. Each Sunday we read the week's output from a fixed roster of the field's highest-quality thinkers — researchers, lab leaders, and operators like Andrew Ng, Andrej Karpathy, Fei-Fei Li, Demis Hassabis, Dario Amodei, Ethan Mollick, Cassie Kozyrkov, and Erik Brynjolfsson — plus the primary research, regulator, and lab feeds.

The brief comes in two speeds: a 4-minute Quick Hits skim, then a longer Synthesis that connects the week's moves, takes a position, and links to the primary work. We optimize for quality over influence, link to the source (the paper, the post, the talk) rather than the hype around it, and flag anything unconfirmed. No "10 AI tools you need today."